Familial Mediterranean Fever (FMF )

Also known as: Familial Mediterranean Syndrome / Familial Mediterranean Fever (FMF) / Familial Mediterranean Fever / Periodic fever syndromes / Familial Mediterranean fever (disorder) / Familial recurrent polyserositis

DrugDrug NameDrug Description
DB06168CanakinumabAn interleukin-1β blocker used to treat Periodic Fever Syndromes such as Cryopyrin-Associated Periodic Syndromes (CAPS) and Familial Mediterranean Fever (FMF), and also to treat active Systemic Juvenile Idiopathic Arthritis (SJIA).
DB01394ColchicineAn alkaloid used to treat gout and Familial Mediterranean Fever as well as prevent major cardiovascular events.
DrugDrug NamePhaseStatusCount
DB01394Colchicine1Completed1
DB06168Canakinumab2Completed1
DB16396Goflikicept2Recruiting2
DB06372Rilonacept2Completed2
DB06273Tocilizumab2Completed1
DB06405Eprodisate2 / 3Completed1
DB00026Anakinra3Completed1
DB01394Colchicine4Completed1